Early vasospasm on admission angiography in patients with aneurysmal subarachnoid hemorrhage is a predictor for in-hospital complications and poor outcome

被引:107
作者
Baldwin, ME
Macdonald, RL
Huo, DZ
Novakovia, RL
Goldenberg, FD
Frank, JI
Rosengart, AJ
机构
[1] Univ Chicago, Med Ctr, Neurocrit Care & Acute Stroke Program, Chicago, IL 60637 USA
[2] Univ Chicago, Med Ctr, Dept Surg, Neurosurg Sect, Chicago, IL 60637 USA
[3] Univ Chicago, Med Ctr, Dept Neurol, Chicago, IL 60637 USA
[4] Univ Chicago, Med Ctr, Dept Hlth Studies, Chicago, IL 60637 USA
[5] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA
关键词
cerebral arteries; cerebral infarction; complications; subarachnoid hemorrhage; vasospasm;
D O I
10.1161/01.STR.0000144654.79393.cf
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-Early vasospasm (EVSP), defined here as arterial narrowing seen on diagnostic angiography within the first 48 hours of aneurysmal rupture, is a rarely reported and poorly defined phenomenon in patients with subarachnoid hemorrhage (SAH). The purpose of this study was to characterize EVSP in a large database of such patients. Methods-We analyzed the relationship of EVSP to clinical characteristics, in-hospital complications, and outcome at 3 months among 3478 patients entered into 4 prospective, randomized, double-blind, placebo-controlled trials of tirilazad conducted in neurosurgical centers around the world between 1991 and 1997. Results-Three hundred thirty-nine (10%) of 3478 patients had EVSP. EVSP was significantly more likely in patients with poor neurological grade on admission, history of SAH, intracerebral hematoma, larger aneurysm, thick SAH on cranial computed tomography, and intraventricular hemorrhage. EVSP was not associated with delayed cerebral vasospasm. After adjustment for differences in admission characteristics, EVSP was associated with cerebral infarction (adjusted odds ratios [OR]=1.51; 95% CI, 1.18 to 1.94; P=0.001), neurological worsening (OR=1.41; 95% CI, 1.10 to 1.81; P=0.007), and unfavorable outcome (OR=1.51; 95% CI, 1.15 to 2.00; P=0.003). In addition, there was a trend for patients with increasingly severe EVSP to have unfavorable outcome (OR=1.84 for mild and OR=2.66 for moderate/severe EVSP). Conclusions-EVSP was seen in 10% of SAH patients and was predictive of cerebral infarction and neurological worsening as well as unfavorable outcome at 3 months. EVSP was not associated with late vasospasm. EVSP may be as important as delayed vasospasm in predicting complications and long-term morbidity in SAH patients.
引用
收藏
页码:2506 / 2511
页数:6
相关论文
共 32 条
[1]   Postpartum cerebral vasospasm treated with hypervolemic therapy [J].
Akins, PT ;
Levy, KJ ;
Cross, AH ;
Goldberg, MP ;
Schieber, MH .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1996, 175 (05) :1386-1388
[2]   Acute vasoconstriction after subarachnoid hemorrhage [J].
Bederson, JB ;
Levy, AL ;
Ding, WH ;
Kahn, R ;
DiPerna, CA ;
Jenkins, AL III ;
Vallabhajosyula, P .
NEUROSURGERY, 1998, 42 (02) :352-360
[3]   BIPHASIC RESPONSE OF CEREBRAL VASOSPASM IN EXPERIMENTAL SUBARACHNOID HEMORRHAGE [J].
BRAWLEY, BW ;
STRANDNESS, DE ;
KELLY, WA .
JOURNAL OF NEUROSURGERY, 1968, 28 (01) :1-+
[4]   INITIAL AND RECURRENT BLEEDING ARE THE MAJOR CAUSES OF DEATH FOLLOWING SUBARACHNOID HEMORRHAGE [J].
BRODERICK, JP ;
BROTT, TG ;
DULDNER, JE ;
TOMSICK, T ;
LEACH, A .
STROKE, 1994, 25 (07) :1342-1347
[5]   THE ROLE OF VASOPRESSIN IN ACUTE CEREBRAL VASOSPASM - EFFECT ON SPASM OF A VASOPRESSIN ANTAGONIST OR VASOPRESSIN ANTISERUM [J].
DELGADO, TJ ;
ARBAB, MAR ;
WARBERG, J ;
SVENDGAARD, NA .
JOURNAL OF NEUROSURGERY, 1988, 68 (02) :266-273
[6]  
Dorsch N W, 1994, J Clin Neurosci, V1, P19, DOI 10.1016/0967-5868(94)90005-1
[7]  
DRAKE CG, 1988, J NEUROSURG, V68, P985
[8]  
DUBLIN AB, 1980, SURG NEUROL, V13, P19
[9]   A RANDOMIZED CONTROLLED TRIAL OF HIGH-DOSE INTRAVENOUS NICARDIPINE IN ANEURYSMAL SUBARACHNOID HEMORRHAGE - A REPORT OF THE COOPERATIVE ANEURYSM STUDY [J].
HALEY, EC ;
KASSELL, NF ;
TORNER, JC ;
SPETZLER, RF ;
ZABRAMSKI, J ;
CULICCHIA, F ;
CARTER, LP ;
FEINBERG, W ;
URBINA, C ;
LOPEZ, L ;
BROWN, D ;
TALLMAN, D ;
SELMAN, WR ;
HARRINGTON, F ;
WARF, B ;
BARNETT, GH ;
LITTLE, J ;
PALMER, J ;
SOLOMON, RA ;
LENNIHAN, L ;
FINK, M ;
BECKFORD, A ;
FRIEDMAN, AH ;
BOWMAN, M ;
GENTRY, A ;
CAMPBELL, RL ;
SHAPIRO, S ;
FARLOW, M ;
KAY, S ;
HORNER, T ;
LEIPZIG, T ;
REDELMAN, K ;
NAUTA, HJ ;
PREZIOSI, T ;
HANLEY, D ;
BOREL, C ;
SALIBI, S ;
HEROS, RC ;
KISTLER, JP ;
DIEBOLD, P ;
MUIZELAAR, JP ;
TURNER, R ;
KAMSHEH, W ;
BOUMA, G ;
MUIZELAAR, JP ;
MOHR, G ;
BOJANOWSKI, M ;
BERNIER, G ;
DUQUETTE, P ;
LAPLANTE, P .
JOURNAL OF NEUROSURGERY, 1993, 78 (04) :537-547
[10]   A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: A cooperative study in North America [J].
Haley, EC ;
Kassell, NF ;
AppersonHansen, C ;
Maile, MH ;
Alves, WM .
JOURNAL OF NEUROSURGERY, 1997, 86 (03) :467-474